Request Free Sample ×
UK Blood Grouping Reagents Market Research Report-Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Blood Grouping Reagents Market

ID: MRFR/HC/51492-HCR
200 Pages
Rahul Gotadki
March 2026

UK Blood Grouping Reagents Market Research Report: Size, Share, Trend Analysis By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), By Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, Antigen Typing) and By End Users (Hospitals, Blood Banks, Clinical Laboratories) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Blood Grouping Reagents Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

UK Blood Grouping Reagents Market Summary

As per Market Research Future analysis, the UK blood grouping-reagents market size was estimated at 0.104 USD Million in 2024. The UK blood grouping-reagents market is projected to grow from 0.112 USD Million in 2025 to 0.23 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The UK blood grouping-reagents market is poised for growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements are enhancing the efficiency and accuracy of blood grouping reagents.
  • The regulatory compliance landscape is becoming increasingly stringent, impacting market dynamics.
  • The rising demand for blood safety is propelling innovations in blood grouping technologies.
  • Key market drivers include increasing healthcare expenditure and growing awareness of blood donation.

Market Size & Forecast

2024 Market Size 0.104 (USD Million)
2035 Market Size 0.23 (USD Million)
CAGR (2025 - 2035) 7.46%

Major Players

Abbott Laboratories (US), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Bio-Rad Laboratories (US), Grifols (ES), Ortho Clinical Diagnostics (US), Beckman Coulter (US), Merck KGaA (DE), F. Hoffmann-La Roche (CH)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

UK Blood Grouping Reagents Market Trends

The blood grouping-reagents market is currently experiencing notable developments. This growth is driven by advancements in technology and an increasing demand for accurate blood typing. The rise in diagnostic testing, particularly in transfusion medicine and organ transplantation, has led to a greater emphasis on the reliability of blood grouping reagents. Furthermore, the growing awareness of blood safety and the need for precise matching in transfusions are influencing the market dynamics. Regulatory bodies are also playing a crucial role in ensuring that the reagents meet stringent quality standards, which may enhance consumer confidence and drive market growth. In addition, the blood grouping-reagents market is witnessing a shift towards automation and the integration of digital technologies. This trend appears to be fostering efficiency in laboratories, reducing human error, and expediting the testing process. The increasing prevalence of blood-related disorders and the rising number of surgical procedures are likely to further propel the demand for these reagents. As the market evolves, stakeholders must remain vigilant to adapt to changing regulations and technological advancements that could shape the future landscape of blood grouping reagents.

Technological Advancements

The blood grouping-reagents market is benefiting from innovations in technology, which enhance the accuracy and efficiency of blood typing processes. Automated systems and advanced diagnostic tools are being integrated into laboratories, streamlining workflows and minimizing errors. This trend is likely to improve the overall reliability of blood grouping, thereby increasing the demand for high-quality reagents.

Regulatory Compliance

Stringent regulations imposed by health authorities are shaping the blood grouping-reagents market. Compliance with these regulations ensures that products meet safety and efficacy standards, which is crucial for maintaining public trust. Manufacturers are increasingly focusing on quality assurance and regulatory adherence, which may influence their market strategies and product offerings.

Rising Demand for Blood Safety

There is a growing emphasis on blood safety within the healthcare sector, which is driving the blood grouping-reagents market. The need for precise blood matching in transfusions and organ transplants is becoming more critical, leading to an increased demand for reliable reagents. This trend suggests that stakeholders must prioritize the development of products that enhance blood safety and compatibility.

UK Blood Grouping Reagents Market Drivers

Increasing Healthcare Expenditure

The blood grouping-reagents market will benefit from the rising healthcare expenditure in the UK. As the government and private sectors allocate more funds towards healthcare, the demand for diagnostic tools, including blood grouping reagents, is expected to increase. In 2025, healthcare spending in the UK is projected to reach approximately £200 billion, which may lead to enhanced procurement of essential medical supplies. This trend indicates a growing recognition of the importance of accurate blood typing in transfusions and organ transplants, thereby driving the blood grouping-reagents market. Furthermore, increased funding for research and development in medical technologies could foster innovation in blood grouping reagents, potentially improving their efficacy and reliability.

Growing Awareness of Blood Donation

The blood grouping-reagents market is anticipated to experience growth due to the increasing awareness surrounding blood donation in the UK. Campaigns aimed at educating the public about the importance of blood donation have gained momentum, leading to a rise in voluntary donations. This heightened awareness is likely to result in a greater need for blood grouping reagents, as accurate typing is crucial for ensuring compatibility in transfusions. In 2025, it is estimated that blood donation rates may increase by 15%, further propelling the demand for reagents. The blood grouping-reagents market stands to benefit from this trend, as healthcare facilities will require more reagents to process the growing number of donations.

Rising Incidence of Blood Disorders

The blood grouping-reagents market will expand in response to the rising incidence of blood disorders in the UK. Conditions such as anemia, hemophilia, and sickle cell disease are becoming more prevalent, necessitating accurate blood typing for effective management and treatment. The increasing patient population requiring blood transfusions and specialized treatments is likely to drive the demand for blood grouping reagents. In 2025, it is projected that the prevalence of blood disorders may increase by 10%, further emphasizing the need for reliable reagents. This trend suggests that healthcare providers will increasingly rely on blood grouping reagents to ensure safe and effective patient care.

Advancements in Diagnostic Technologies

The blood grouping-reagents market is poised for growth due to advancements in diagnostic technologies. Innovations such as automated blood typing systems and rapid testing kits are enhancing the efficiency and accuracy of blood grouping processes. These technological improvements are likely to increase the adoption of blood grouping reagents in clinical laboratories and blood banks across the UK. In 2025, the market for automated blood typing systems is projected to grow by 20%, indicating a shift towards more sophisticated diagnostic solutions. As healthcare providers seek to improve patient outcomes, the demand for high-quality blood grouping reagents is expected to rise, thereby positively impacting the market.

Regulatory Support for Blood Safety Initiatives

The blood grouping-reagents market is likely to benefit from regulatory support aimed at enhancing blood safety initiatives in the UK. Government agencies are implementing stringent regulations to ensure the safety and quality of blood products, which includes the use of reliable blood grouping reagents. In 2025, it is anticipated that new regulations will be introduced, mandating the use of advanced reagents in blood banks and hospitals. This regulatory environment is expected to drive the demand for high-quality blood grouping reagents, as compliance with safety standards becomes increasingly critical. Consequently, the blood grouping-reagents market may see a surge in demand as healthcare facilities strive to meet these regulatory requirements.

Market Segment Insights

By Product: Consumables (Largest) vs. Instruments (Fastest-Growing)

In the UK blood grouping-reagents market, the segment share is heavily tilted towards consumables, which dominate the landscape due to their essential role in routine blood testing and diagnostics. Instruments hold a smaller share but are gaining traction due to technological advancements and the increasing automation of laboratory processes. This market distribution reflects the critical necessity of consumables while highlighting the emerging potential of instruments. Growth trends indicate a strong trajectory for instruments as laboratories seek efficiency and precision, driven by technological innovations and increased demand for automation. Furthermore, the rising incidence of blood disorders fosters a consistent need for consumables, while instruments are set to expand as healthcare providers invest in modernizing their facilities. The interplay of these factors creates a dynamic market environment that fosters significant competition across both segments.

Consumables (Dominant) vs. Instruments (Emerging)

Consumables dominate the UK blood grouping-reagents market, primarily comprising reagents and kits that are indispensable for blood typing and compatibility testing. Their extensive usage in diagnostics ensures consistent demand, making them a mainstay in laboratories. Conversely, instruments are emerging as a vital segment due to innovations in blood analysis technology and increasing investments from healthcare providers. These instruments enhance accuracy and efficiency in testing procedures, positioning them as a growing segment. The potential of instruments is further augmented by the demand for point-of-care testing and the trend toward integrated diagnostic solutions, which offer significant growth opportunities in the evolving landscape.

By Technique: PCR-based (Largest) vs. Assay-Based (Fastest-Growing)

In the UK blood grouping-reagents market, PCR-based techniques have established themselves as the largest segment, dominating the market share due to their reliability and accuracy. Assay-based techniques, while currently smaller in market share, are making strides in popularity, especially among healthcare providers seeking efficiency in diagnostics and patient care. The growth trajectory of these techniques reflects the ongoing advancements in medical technology and increasing investments in research and development within the sector. Growth trends indicate that the demand for assay-based techniques is accelerating, driven by technological innovations and the need for quicker diagnostic results. The adoption of automation and integration of advanced software in laboratory procedures are significant contributors to this surge. Moreover, regulatory endorsements and an increasing focus on personalized medicine bolster the potential of these techniques, positioning them as key players in the evolving landscape of the UK blood grouping-reagents market.

Technique: PCR-based (Dominant) vs. Assay-Based (Emerging)

PCR-based techniques are characterized by their high sensitivity and specificity, making them a cornerstone in the diagnostics industry and helping lead the UK blood grouping-reagents market. They allow for rapid detection of blood group antigens and are relied upon in critical medical decisions. Assay-based techniques, conversely, are emerging as a faster and more efficient alternative, especially in high-throughput environments. These techniques leverage advanced methodologies that streamline the testing process, thus reducing turnaround times significantly. The integration of these newer techniques fosters innovation within the market while promising improvements in operational efficiencies.

By Test Type: Blood Group and Phenotype (Largest) vs. Antibody Identification (Fastest-Growing)

In the UK blood grouping-reagents market, Blood Group and Phenotype tests hold the largest market share, driven by their essential role in blood transfusion and organ transplantation procedures. The segment is preferred due to its reliability and accuracy, leading to significant adoption in clinical settings. Antibody Screening and Cross-matching Tests also contribute to the market, albeit at a lower share, as they serve complementary functions in ensuring compatibility and safety in transfusion practices. The growth trends in this segment are largely influenced by advancements in testing technologies and increasing awareness of blood safety. Antibody Identification is emerging as the fastest-growing segment due to its critical role in identifying incompatible donor-recipient pairs, thereby minimizing transfusion reactions. The overall trend is propelled by an aging population and a rising demand for blood products in healthcare, prompting continuous innovation and investment in these testing methods.

Blood Group and Phenotype (Dominant) vs. Antibody Identification (Emerging)

Blood Group and Phenotype tests are the dominant segment within the UK blood grouping-reagents market, characterized by high demand due to their fundamental importance in transfusion medicine. These tests ensure accurate blood type identification, which is crucial for patient safety. Dominating the market, they leverage established methodologies and a wide range of applications in healthcare. On the other hand, Antibody Identification is an emerging segment, rapidly gaining traction. It focuses on detecting specific antibodies that may cause adverse reactions, thereby ensuring safer transfusions. This segment is characterized by innovative technologies that enhance the precision of identifying incompatibilities between donors and recipients, fulfilling an increasing need as the awareness of transfusion safety grows.

By End User: Hospitals (Largest) vs. Blood Banks (Fastest-Growing)

In the UK blood grouping-reagents market, hospitals dominate the end user segment, holding the largest market share due to their extensive need for blood tests and transfusions. Blood banks follow closely as key players, providing essential services in the collection, processing, and distribution of blood products. Clinical laboratories also serve a significant role, contributing to the overall market by offering various tests but typically rely on hospitals and blood banks for their supplies. Growth trends in this segment are largely driven by advances in technology and increasing demand for safe blood transfusions. Hospitals are expanding their capabilities, while blood banks are seeing a surge as donor participation increases. Furthermore, clinical laboratories are enhancing their testing capabilities, driven by regulatory requirements and growing awareness about blood safety. These factors are expected to continue pushing the sector forward.

Hospitals (Dominant) vs. Blood Banks (Emerging)

Hospitals are the dominant end users in the UK blood grouping-reagents market, as they require robust inventory management and a wide variety of reagents to ensure safe blood transfusions. Their extensive operating scales and established procedures allow for consistent demand, making them crucial stakeholders. In contrast, blood banks are emerging as significant players, driven by innovation and public health initiatives aimed at enhancing blood donation drives. Their role is becoming increasingly pivotal in ensuring an adequate supply of safe blood, particularly as they adopt modern technologies for processing and storage. This dynamic creates a competitive yet collaborative environment between hospitals and blood banks in ensuring sufficient blood resources.

Blood Grouping Reagents Market End User Insights

Blood Grouping Reagents Market End User Insights

The End User segment of the UK Blood Grouping Reagents Market encompasses critical sectors such as Hospitals, Blood Banks, and Clinical Laboratories, each playing a vital role in the healthcare system. Hospitals are central to patient care, relying heavily on accurate blood grouping for safe transfusions and surgeries, making their need for reliable reagents crucial.

Blood Banks focus on the collection and preservation of blood components, thus requiring high-quality reagents to ensure compatibility and efficiency in matching donors to recipients.Clinical Laboratories conduct a variety of analyses, providing essential data for diagnosing medical conditions, which necessitates the use of precise blood grouping reagents to ensure accurate results. As the demand for safe blood transfusions and the need for effective diagnostic tools continue to rise in the UK, the significance of this segment also grows, driven by advancements in technology and an increasing awareness of blood safety.

Overall, this segment represents a fundamental aspect of healthcare delivery in the UK, where the emphasis on improving health outcomes is paramount.

Get more detailed insights about UK Blood Grouping Reagents Market
Request Free Sample

Key Players and Competitive Insights

The blood grouping-reagents market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Abbott Laboratories (US), Thermo Fisher Scientific (US), and Siemens Healthineers (DE) are at the forefront, leveraging their technological capabilities to enhance product offerings. Abbott Laboratories (US) focuses on developing advanced reagents that improve the accuracy and efficiency of blood typing, while Thermo Fisher Scientific (US) emphasizes digital transformation to streamline laboratory processes. Siemens Healthineers (DE) is actively pursuing partnerships to expand its market reach, indicating a trend towards collaborative innovation that enhances competitive dynamics.In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and optimize operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they set industry standards and drive technological advancements that smaller firms may struggle to match.

In October Bio-Rad Laboratories (US) announced the launch of a new line of blood grouping reagents designed to enhance compatibility testing. This strategic move is likely to strengthen Bio-Rad's position in the market by addressing the growing demand for precise and reliable blood typing solutions. The introduction of these reagents aligns with the company's commitment to innovation and could potentially capture a larger share of the market.

In September Grifols (ES) expanded its product portfolio by acquiring a smaller firm specializing in blood typing technologies. This acquisition not only broadens Grifols' capabilities but also enhances its competitive edge by integrating advanced technologies into its existing offerings. Such strategic actions suggest a trend towards consolidation in the market, where larger players seek to bolster their positions through targeted acquisitions.

In August Ortho Clinical Diagnostics (US) launched a new digital platform aimed at improving laboratory workflows and data management for blood grouping. This initiative reflects a growing emphasis on digitalization within the industry, as companies recognize the importance of integrating technology to enhance operational efficiency and customer satisfaction. The move positions Ortho Clinical Diagnostics as a leader in the digital transformation of blood testing.

As of November current competitive trends indicate a strong focus on digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming increasingly vital, as companies collaborate to leverage complementary strengths and drive innovation. The competitive landscape is likely to evolve from traditional price-based competition towards a model that prioritizes technological advancement, supply chain reliability, and innovative solutions. This shift suggests that companies that can effectively differentiate themselves through innovation and strategic partnerships will be better positioned for future success.

Key Companies in the UK Blood Grouping Reagents Market include

Industry Developments

The UK Blood Grouping Reagents Market has seen significant developments recently, particularly with notable advancements from key players like PerkinElmer, Siemens Healthineers, and Abbott Laboratories. In 2023, Abbott Laboratories expanded its product line, enhancing its blood grouping reagents to meet increasing demand in healthcare facilities across the UK. The market has also been influenced by the growing necessity for efficient blood donation and transfusion processes, elevating the need for high-quality reagents. In terms of mergers and acquisitions, no recent developments have been recorded involving the specified companies that meet the criteria of being publicly known and reported reliably.

However, over the past two to three years, companies like Roche and Bio-Rad Laboratories have increased their market valuation significantly due to strategic innovations and collaborations, which bolstered their product offerings. Additionally, the UK government has emphasized advancements in biotechnology, further fueling market growth with support for Research and Development initiatives. This focus on improving healthcare infrastructure in the UK has become essential in addressing public health challenges, particularly in blood management and diagnostics.

Future Outlook

UK Blood Grouping Reagents Market Future Outlook

The Blood Grouping Reagents Market is projected to grow at a 7.46% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

New opportunities lie in:

  • Development of automated blood typing systems for hospitals
  • Expansion of e-commerce platforms for reagent distribution
  • Partnerships with diagnostic labs for customized reagent solutions

By 2035, the market is expected to achieve robust growth and enhanced competitive positioning.

Market Segmentation

UK Blood Grouping Reagents Market Product Outlook

  • Consumables
  • Instruments

UK Blood Grouping Reagents Market End User Outlook

  • Hospitals
  • Blood Banks
  • Clinical Laboratories

UK Blood Grouping Reagents Market Technique Outlook

  • PCR-based and Microarray Technique
  • Assay-Based Techniques
  • Massively Parallel Sequencing Techniques
  • Serology
  • Other Techniques

UK Blood Grouping Reagents Market Test Type Outlook

  • Blood Group and Phenotype
  • Antibody Screening
  • Cross-matching Tests
  • Antibody Identification
  • Coombs Tests
  • Antigen Typing

Report Scope

MARKET SIZE 2024 0.104(USD Million)
MARKET SIZE 2025 0.112(USD Million)
MARKET SIZE 2035 0.23(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.46% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott Laboratories (US), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Bio-Rad Laboratories (US), Grifols (ES), Ortho Clinical Diagnostics (US), Beckman Coulter (US), Merck KGaA (DE), F. Hoffmann-La Roche (CH)
Segments Covered Product, Technique, Test Type, End User
Key Market Opportunities Advancements in automation and digitalization enhance efficiency in the blood grouping-reagents market.
Key Market Dynamics Rising demand for advanced blood grouping reagents driven by regulatory changes and technological innovations in diagnostics.
Countries Covered UK
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

FAQs

What is the projected market valuation for the UK blood grouping-reagents market in 2035?

<p>The projected market valuation for the UK blood grouping-reagents market in 2035 is expected to reach $0.23 Million.</p>

What was the market valuation for the UK blood grouping-reagents market in 2024?

<p>The overall market valuation for the UK blood grouping-reagents market was $0.104 Million in 2024.</p>

What is the expected CAGR for the UK blood grouping-reagents market during the forecast period 2025 - 2035?

<p>The expected CAGR for the UK blood grouping-reagents market during the forecast period 2025 - 2035 is 7.46%.</p>

Which companies are considered key players in the UK blood grouping-reagents market?

<p>Key players in the UK blood grouping-reagents market include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, and Bio-Rad Laboratories.</p>

What are the main product segments in the UK blood grouping-reagents market?

<p>The main product segments in the UK blood grouping-reagents market include consumables and instruments, with consumables valued at $0.065 - $0.15 Million.</p>

What techniques are utilized in the UK blood grouping-reagents market?

<p>Techniques utilized in the UK blood grouping-reagents market include PCR-based and microarray techniques, assay-based techniques, and serology, among others.</p>

What is the valuation range for antibody screening tests in the UK blood grouping-reagents market?

<p>The valuation range for antibody screening tests in the UK blood grouping-reagents market is $0.02 - $0.045 Million.</p>

How do hospitals and blood banks contribute to the UK blood grouping-reagents market?

<p>Hospitals and blood banks contribute to the UK blood grouping-reagents market, with hospitals valued at $0.045 - $0.1 Million and blood banks at $0.035 - $0.075 Million.</p>

What is the valuation range for cross-matching tests in the UK blood grouping-reagents market?

<p>The valuation range for cross-matching tests in the UK blood grouping-reagents market is $0.018 - $0.04 Million.</p>

What is the significance of the 2025 - 2035 forecast period for the UK blood grouping-reagents market?

<p>The 2025 - 2035 forecast period is significant for the UK blood grouping-reagents market as it indicates a growth trajectory with an expected CAGR of 7.46%.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓